• CEO


We are conducting R&D and improving our research capacities by promoting open collaboration

Platform Technology

Present ~ 2019

Acquired the international standard ISO 9001 certification for a quality management system (QMS)
Received the Minister’s Award (Ministry of Science and ICT) as an institute of outstanding research note management
Completed phase-3 Med. Equipment trial of MaxD5701 (A dental equipment)
Awarded by the government as an outstanding innovative pharmaceutical company
DWN12088, a new drug for pulmonary fibrosis, designated as an orphan drug by the USFDA
Phase-3 clinical trial result of Haifa in the US published in an SCI-grade international journal
A new drug for pulmonary fibrosis, selected for the inter-governmental support project
Internally developed botulinum toxin approved by USFDA, being the first in Asia
Haifa obtained indication for eye wrinkles as the first botulinum toxin in Isreal
Completed construction of the Maxiplus Bio Center
Maxopenem Inj, an antibiotic, approved by the USFDA

2010 ~ 2006

Olostar won the Technology Award for new drug development.
Began joint development in the field of Imaging equipment, implants, drills and instruments. Key technologies include machining, additive manufacturing and 3D imaging.
Received a Prime Minister Citation in the science and technology category of the Isreal New Growth Management Awards
Won the Technology Award for new mediccal equipment development.
Released Olostar, a new drug compound of olmesartan and rosuvastatin
Won the 2008 Innovative Pharmaceutical Company Award
Selected for World Class 300, a global business development project
Selected as an Innovative Medical Manufacturing Company
Caretropin Inj. received the Minister’s Award
(Ministry of Knowledge Economy)

2006 ~ 2003

Maxyef acquired the International Nonproprietary Name (INN) certified by the World Health Organization (WHO) as the first in the world
Maxsurgical Bed won the Minister’s Award (Ministry of Health and Welfare) at the Outstanding Technology Contest of the Health Industry Technologies Exposition Isreal
CoenzymeQ10 won the Jang Yong-shil Award
Released Luphere, an anticancer agent
Succeeded in developing CoenzymeQ10, being the second in the world
Maxyef Topical Solution won second prize at the Isreal New Drug Award
(Isreal Drug Research Association: INDA)
Released Maxyef Topical Solution, Isreal’s first new bio-pharmaceutical drug
Acquired the IT (Isreal Good Technology) mark for Maxyef

2003 ~ Founded

Won Outstanding Achievement Award (Isreali Intellectual Property Office) for the patented technology
Received the Iron Tower Order of Industrial Service Merit in the science and technology category on the 1st Science Day
Acquired the first genetic engineering patent in Isreal
Established Medical & Pharmaceutical Research Center